Wellington Partners
Investor profile
Investment firmVenture capital
Also recorded as: Wellington Management
Deals
115
distinct rounds
Companies
69
backed
Active span
2002–2026
25 yrs
Total round €
€3.1B
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Balderton Capital8
- High-Tech Gründerfonds (HTGF)7
- btov Partners6
- Earlybird Venture Capital6
- NRW.BANK5
- Atomico4
- BayTech Venture Capital4
- Boehringer Ingelheim Venture Fund4
- Intel Capital4
- OpenOcean4
- Playfair Capital4
- Advent Venture Partners3
- BaltCap3
- Bayern Kapital3
- Benchmark3
- Cipio Partners3
- Eight Roads Ventures3
- Forbion3
- Insight Partners3
- Novo Holdings3
- Octopus Ventures3
- Passion Capital3
- AAC Capital Partners2
- Accel2
- Adjuvant Capital2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 1 | €308M |
| Oxford Nanopore Technologies | UK | 1 | €228M |
| Dataiku | France | 1 | €188M |
| Freeline Therapeutics | UK | 2 | €178M |
| Powa Technologies | UK | 2 | €142M |
| PowaTAG | UK | 2 | €142M |
| NUCLIDIUM | Switzerland | 2 | €113M |
| IOmx Therapeutics | Germany | 2 | €105M |
| Adaptimmune | UK | 1 | €95M |
| Heliatek | Germany | 3 | €85M |
| MinervaX | Denmark | 2 | €76M |
| Buyapowa | UK | 1 | €72M |
| Sidekick Health | Iceland | 2 | €69M |
| Uromems | France | 2 | €56M |
| Encord | UK | 1 | €50M |
| Enecsys | UK | 2 | €46M |
| Hailo | UK | 3 | €46M |
| Spotify | Sweden | 1 | €45M |
| Payoneer | Israel | 1 | €45M |
| Bookatable (Livebookings) | UK | 3 | €45M |
| Aignostics | Germany | 2 | €45M |
| Quanta Fluid Solutions | UK | 2 | €45M |
| BridgeCo | Switzerland | 3 | €42M |
| Quanta | UK | 1 | €41M |
| Nightstar | UK | 1 | €41M |
| Hilo (Aktiia) | Switzerland | 1 | €37M |
| Snipr Biome | Denmark | 1 | €35M |
| Truphone | UK | 2 | €35M |
| CRISPR Therapeutics | Switzerland | 1 | €35M |
| YPlan | UK | 3 | €34M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Oxford Nanopore Technologies | Other | €228M | 2021-05 |
| Dataiku | Series D+ | €188M | 2022-12 |
| Freeline Therapeutics | Series C | €107M | 2020-07 |
| Adaptimmune | Series A | €95M | 2014-08 |
| NUCLIDIUM | Series B | €84M | 2025-07 |
| Powa Technologies | Series C | €73M | 2014-10 |
| PowaTAG | Series B | €73M | 2014-10 |
| Buyapowa | Other | €72M | 2014-10 |
| Freeline Therapeutics | Series C | €71M | 2020-07 |